Patients need EUR 800,000 to conduct a therapy study for BC007 in ME/CFS.
This drug neutralizes harmful autoantibodies which were found in ME/CFS as well as in long covid.
However, there is no research funding for ME/CFS.
There is no approved drug for the treatment of ME/CFS in Germany, 240,000 affected people suffer in severe pain.
With your donation you can help to make this study possible!
Brückeverbindet e.V. IBAN: DE43 1005 0000 0191 0769 61 BIC: BELADEBEXXX
Purpose: „BC007 für ME/CFS (via Solarprognose)“
Donation receipts are issued by the association Brückeverbindet, please add your email and postal address for the donation donation receipt!